Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Blood
|
July 1, 1996
Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study
S P Ivy, R S Olshefski, B J Taylor, et al.
Thrombosis Research
|
October 24, 2015
Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials
A S Mansfield, A J Tafur, D Vulih, et al.
Blood
|
April 1, 1997
Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 human leukemia cell line
M Gong, J Yess, T Connolly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2014
The role of age on dose-limiting toxicities in phase I dose-escalation trials
A Schwandt, P J Harris, S Hunsberger, et al.
Anticancer Research
|
April 19, 2000
Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs
S Martin-Aragon, S K Mukherjee, B J Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1987
Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas
C R Fairchild, S P Ivy, T Rushmore, et al.
Gynecologic Oncology
|
April 22, 2015
A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: a trial of the Princess Margaret, Chicago and California Phase II Consortia
H Hirte, S Lheureux, G F Fleming, et al.
The Journal of Biological Chemistry
|
December 15, 1988
Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line
S P Ivy, A Tulpule, C R Fairchild, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2010
A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study
J J Biagi, A M Oza, H I Chalchal, et al.
Cancer Research
|
October 1, 1987
Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells
C R Fairchild, S P Ivy, C S Kao-Shan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Blood
|
July 1, 1996
Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study
S P Ivy, R S Olshefski, B J Taylor, et al.
Thrombosis Research
|
October 24, 2015
Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials
A S Mansfield, A J Tafur, D Vulih, et al.
Blood
|
April 1, 1997
Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 human leukemia cell line
M Gong, J Yess, T Connolly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2014
The role of age on dose-limiting toxicities in phase I dose-escalation trials
A Schwandt, P J Harris, S Hunsberger, et al.
Anticancer Research
|
April 19, 2000
Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs
S Martin-Aragon, S K Mukherjee, B J Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1987
Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas
C R Fairchild, S P Ivy, T Rushmore, et al.
Gynecologic Oncology
|
April 22, 2015
A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: a trial of the Princess Margaret, Chicago and California Phase II Consortia
H Hirte, S Lheureux, G F Fleming, et al.
The Journal of Biological Chemistry
|
December 15, 1988
Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line
S P Ivy, A Tulpule, C R Fairchild, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2010
A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study
J J Biagi, A M Oza, H I Chalchal, et al.
Cancer Research
|
October 1, 1987
Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells
C R Fairchild, S P Ivy, C S Kao-Shan, et al.
Page
of 3